Fellow Rotary Enthusiast, SevenStock has signed up to help make a positive difference this year, and with all of your support and help, we will.


The Southern California RX-7 Club and RotaryNews.Com are very happy to announce that, they have teamed up with Mazda R&D to help raise awareness and donations for the Juvenile Diabetes Research Foundation International Charity, through this year’s SevenStock-5 event. Mazda has signed on to be a corporate Gold Sponsor for the Walk To Cure Diabetes this year and with the strong relationship Mazda R&D enjoys with the So-Cal7s Club and RotaryNews; we felt that SevenStock would be the perfect venue to lend a hand and create some exposure to this worthy cause. A percentage of the proceeds generated at the SevenStock-5 Raffle, will be donated to the charity through the Mazda R&D Center. Please help us support this very important cause by sending a donation:
*directly to the JDRFI @ their website
or
look for one of the JDRF donation boxes @ SevenStock-5 this year.


*please let us know if you sent a direct donation by contacting us

The following is a little more detailed information on the Juvenile Diabetes Research Foundation International activities and research.

• JDRF is the only major diabetes organization focused exclusively on research.
• It is the number one nonprofit, nongovernmental funder of diabetes research worldwide.
• Since it’s founding in 1970 by parents of children with juvenile diabetes, JDRF has awarded more than $600 million to diabetes research. In FY2001, it provided $115 million to diabetes research.
• Through its research funding, JDRF has been instrumental in establishing a focus on the needs of all people with diabetes, which has helped set the world's diabetes research agenda to find a cure.
• In a typical year, 85 percent of JDRF's expenditures directly support research and education about research.

• JDRF has three major "cure" goals: restoring normal blood sugar, preventing and reversing diabetes-related complications, and preventing diabetes and its recurrence.
• Through its unique scientific peer and lay review program, JDRF funds the most innovative, cutting-edge research worldwide. In FY2001, the Foundation awarded more than 390 research grants and 130 fellowship and career development awards to scientists in 19 countries throughout the world.
• JDRF structures its research program on a business-world model to ensure that resources are spent most effectively to accelerate progress towards finding a cure.
• Each year, JDRF rigorously evaluates the field of diabetes research worldwide to identify opportunities where JDRF funds will make a difference. In 2001, this review was conducted with assistance from McKinsey and Company. This review confirmed JDRF’s three major "cure" goals and identified specific priority areas including, the generation of beta cells from stem cells, advancing human islet transplantation, preservation of beta cell mass, prevention of end organ damage, genetics of Type 1 diabetes and its complications, prevention and treatment of hypoglycemia.
• The Foundation creates multidisciplinary programs that bring together diabetes researchers from many institutions and such diverse disciplines as molecular biology and genetics, immunology, transplantation and vascular biology to find a cure for diabetes and its complications.

• JDRF leverages its research impact by partnering with and stimulating increased research spending on the part of public and private medical organizations and other entities throughout the world.
• JDRF led the national effort to ensure that federal funding would be available for stem cell research, one of the most promising avenues toward a cure. JDRF created and chaired a coalition of more than 50 major national organizations who worked together to support the research. JDRF was credited by senior Administration officials and journalists with playing the critical role in convincing the Administration to permit this research to move forward.
• JDRF advocates won a major victory in 2000 when Congress approved legislation providing the largest increase for Type 1 diabetes funding in history. Federal Type 1 diabetes research funding at the NIH was increased by more than 60 percent.
• JDRF collaborates with all diabetes stakeholders including individuals with diabetes and their families, world-leading diabetes researchers and academic institutions, foundations, corporations, individual donors and volunteers, government agencies, and biotech/pharmaceutical companies.